15,644 Photos and videos
Pinned Tweet
20 Aug 2025
“You cannot get this level of data and this level of information or power from finger sticks. It's impossible.” @JenniferGoldman explains the "empowerment and efficacy" that comes from CGM GLP-1 RAs working hand-in-hand.
👑 Watch The Sugar Queens ➡️ ms.spr.ly/6011sVvID
1
4
4
850
Could CAR T-cell therapy be the game-changer for severe, hard-to-manage autoimmune diseases?
Explore how this cancer treatment is crossing over to redefine care, and dive into the latest data on targeting B-cell-mediated conditions.
Read here: mdsc.pe/4v9p7Cs
ALT A colorful, artistic rendering of various immune cells, including blue and orange virus-like particles and red, spiky cells, against a pink background, illustrating a microscopic biological interaction.
1
1
28
From Aldosterone Synthase Inhibitors to sGC activators, the therapeutic landscape is evolving. Explore how we’re moving toward precision medicine for every patient.
Watch the full discussion ➡️ x.com/i/broadcasts/1qxoNelwV…
#Nephrology #CME #CKD
27
Learn how to spot early non-motor signs of Parkinson's disease and bridge the critical care gap between primary care and neurology.
Catch up on the episode ➡️ mdsc.pe/4uTmViW
#Parkinsons #Neurology #CME
78
Starting in 1 HOUR ➡️ youtube.com/watch?v=S0QxMEYZ…
Don't miss our live stream with Dr. Alicia Morgans! Get up to speed on the latest 2026 mHSPC data and join the real-time Q&A on treatment intensification with ARPIs. See you there!
#mHSPC #ProstateCancer #Oncology
50
What’s new in mCRC care? 🧬
Join our 15-min live stream with Dr. Pietrantonio & Dr. Oberstein to break down new data and regimens to overcome EGFR inhibitor resistance.
📅 June 19th
⏰ 3:30pm ET
🔗 mdsc.pe/4azXhr3
#Oncology #CME
47
How are the latest targeted therapies shifting how you approach early-stage IDH-mutant glioma?
Explore the new era of glioma management and get expert strategies for timing therapies and tailoring your patient approach.
Read here: mdsc.pe/4uF9m6u
47
Are your IgA Nephropathy patients missing early signs?
Dr. Shikha Wadhwani and patient John Marsala discuss the critical reality of early diagnosis, routine urine checks, and navigating a lifelong kidney disease.
Watch the full discussion ➡️ mdsc.pe/3QhuvEI
120
How have newer targeted therapies shifted how you use radiation in daily glioma management?
Explore the foundational role of radiation oncology today and get actionable tips to optimize treatment timing and outcomes.
Read here:: mdsc.pe/49W4AsS
ALT Microscopic image of a red, spherical cancer cell with irregular surface texture, surrounded by thin, hair-like structures. The background is dark, highlighting the cell's vivid color and detail.
46
Still relying solely on standard anti-infectives for recurrent C. diff?
Discover how balancing immediate treatment with targeted microbiome repair addresses the root cause and breaks the cycle.
Watch the full discussion ➡️ mdsc.pe/4vfyIYm
#Gastroenterology #CDiff #CME
74
Starting in 1 HOUR ➡️ mdsc.pe/4dDTj1w
MASH screening is changing. Join our live expert exchange with Dr. Alkhouri and Dr. Kumar to get a clear look at noninvasive testing and risk stratification strategies. 📉
#Gastroenterology #PrimaryCare #CME
32
As automated insulin delivery and pump options expand, routine care can bring uncertainty.
Join our expert panel to address practical questions and gain insights to confidently integrate pump therapy into T2D management.
🗓️ June 18th
⏰ 5:00pm ET
🔗 mdsc.pe/3ROVqYZ
1
1
38
LIVE TOMORROW ➡️ The Blueprint for Modern mHSPC Care.
Bring your questions as Dr. Alicia Morgans breaks down the key abstracts in mHSPC presented so far in 2026.
📅 June 12th
⏰ 10:30am EST
🔗 youtube.com/watch?v=S0QxMEYZ…
#mHSPC #Oncology #CME
40
LIVE TOMORROW: NITs Demystified. ➡️ mdsc.pe/4dDTj1w
Tune in for a high-impact session on understanding and implementing the noninvasive toolkit for metabolic dysfunction–associated steatohepatitis with Dr. Alkhouri and Dr. Kumar.
🗓️ Thursday, June 11th
⏰ 12:00pm ET
28
Monotherapy is rapidly being relegated to the past.
Learn why early combination protocols are non-negotiable to delay progression to castration resistance and maximize patient survival.
Catch up on the latest data ➡️ mdsc.pe/4wRNM0d
#Oncology #MedEd #CME
72
Starting in 1 HOUR ➡️ mdsc.pe/4wOudWz
The MASH landscape is changing fast. Join our live expert exchange with Dr. Alkhouri and Dr. Allen to walk through the pathway from screening to diagnosis. 📉
#Gastroenterology #PrimaryCare #CME
34
Don't let partial treatment responses leave your patients stranded.
Learn how to leverage a well-tolerated first-line platform and build an effective, combined strategy for residual symptoms.
Catch up on Episode 1 ➡️ mdsc.pe/4dLwjh6
#Depression #Psychiatry #CME
47
SAVE THE DATE 🗓️
Got 15 mins? Join Dr. Filippo Pietrantonio & Dr. Paul Oberstein to tackle EGFR inhibitor resistance and data for novel regimens to overcome it.
📅 June 19th
⏰ 3:30pm ET
🔗 mdsc.pe/4azXhr3
#Oncology #CME
52
LIVE TOMORROW: Enhance your approach to MASH management. ➡️ mdsc.pe/4wOudWz
Tune in for this concise, high-impact session on implementing the newest care pathways with Dr. Alkhouri and Dr. Allen. Don't miss out!
🗓️ Wednesday, June 10th
⏰ 12:00pm ET
21
With lung cancer research moving fast, what's your biggest challenge keeping up with new ALK and SCLC data?
Explore breaking developments and discover practical ways to bring these advancements to your clinic.
Read here: mdsc.pe/4u3Umhw
ALT The image depicts a 3D rendering of blood cells with a prominent protein structure in blue. Red blood cells and purple cell-like structures are scattered against a light pink background.
56
Starting in 1 HOUR ➡️ mdsc.pe/4uS6Zxr
Continuous glucose monitoring is evolving fast. Join our live expert exchange with the Sugar Queens to explore the biggest CGM breakthroughs and emerging technologies straight out of ADA 2026.
#CGM #ADA2026 #MedEd
83